Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002–11

(2015) Andrew W. Dick et al.   HEALTH AFFAIRS

The Untapped Potential of Office-Based Buprenorphine Treatment

(2015) Stacey C. Sigmon   JAMA Psychiatry

Factors contributing to the rise of buprenorphine misuse: 2008–2013

(2014) Theodore J. Cicero et al.   DRUG AND ALCOHOL DEPENDENCE

Confronting the Stigma of Opioid Use Disorder—and Its Treatment

(2014) Yngvild Olsen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic

(2014) Nora D. Volkow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergency Hospitalizations for Unsupervised Prescription Medication Ingestions by Young Children

(2014) M. C. Lovegrove et al.   PEDIATRICS

Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence

(2014) David A. Fiellin et al.   JAMA Internal Medicine

Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes

(2013) Marwan S. Haddad et al.   DRUG AND ALCOHOL DEPENDENCE

Reimbursement and Practice Policies Among Providers of Buprenorphine-Naloxone Treatment

(2013) Angela M. Wisniewski et al.   Substance Abuse

Trends in Opioid Agonist Therapy in the Veterans Health Administration: Is Supply Keeping up with Demand?

(2013) Elizabeth M. Oliva et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Buprenorphine May Not Be as Safe as You Think: A Pediatric Fatality From Unintentional Exposure

(2012) H. K. Kim et al.   PEDIATRICS

Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids

(2011) Raminta Daniulaityte et al.   DRUG AND ALCOHOL DEPENDENCE

The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone

(2011) Bradley D. Stein et al.   DRUG AND ALCOHOL DEPENDENCE

Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians

(2011) Chris-Ellyn Johanson et al.   DRUG AND ALCOHOL DEPENDENCE

Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors

(2011) Elizabeth M. Oliva et al.   DRUG AND ALCOHOL DEPENDENCE

The Evidence Doesn’t Justify Steps By State Medicaid Programs To Restrict Opioid Addiction Treatment With Buprenorphine

(2011) Robin E. Clark et al.   HEALTH AFFAIRS

Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States

(2011) Howard G. Birnbaum et al.   PAIN MEDICINE

Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them

(2011) Elizabeth M. Oliva et al.   Current Psychiatry Reports

Adoption and Implementation of Medications in Addiction Treatment Programs

(2010) Hannah K. Knudsen et al.   Journal of Addiction Medicine

Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone

(2010) Ernest V. Pedapati et al.   Pediatric Critical Care Medicine

A 50-Year-Old Woman Addicted to Heroin

(2008) Charles P. O’Brien   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth

(2008) George E. Woody et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers

(2008) Alexander Y. Walley et al.   JOURNAL OF GENERAL INTERNAL MEDICINE